Publication

Article

Cardiology Review® Online

June 2007
Volume24
Issue 6

Significant coronary stenosis in a patient with normal perfusion

A 58-year-old man with type 2 diabetes and hypertension who was a smoker presented to the outpatient clinic with atypical symptoms.

A 58-year-old man with type 2 diabetes and hypertension who was a smoker presented to the outpatient clinic with atypical symptoms. A 64-slice multislice computed tomography scan showed only minor wall irregularities in the right coronary artery and left anterior descending coronary artery. Borderline significant stenosis in the proximal left circumflex coronary artery was detected, however. The left main, left anterior descending, and left circumflex coronary arteries are shown in the Figure. Panel A shows a 3-dimensional volume-rendered reconstruction, and Panel B shows an enlargement of Panel A, revealing the significant stenosis (arrow). The curved multiplanar reconstruction (Panel C) confirmed the presence of a significant lesion. Subsequently, myocardial perfusion imaging was performed, which showed normal perfusion (Panel D). Accordingly, the patient was not referred for conventional coronary angiography, but medical therapy was started in combination with aggressive risk factor modification.

The left main (LM), left anterior (LAD), and left circumflex coronary arteries (LCx) are shown: (A) 3-dimensional volume-rendered reconstruction; (B) enlargement of Panel A, with arrow indicating significant stenosis; (C) curved multiplanar reconstruction confirmed the presence of a significant lesion (arrow); and (D) normal perfusion is shown in the stress images (top panel) and resting images (lower panel).

Figure.

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Viet Le, DMSc, PA-C | Credit: APAC
Marianna Fontana, MD, PhD: Declines in Kidney Function Frequent in ATTR-CM  | Image Credit: Radcliffe Cardiology
© 2024 MJH Life Sciences

All rights reserved.